Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2010-04-20
2011-12-06
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S439000, C514S054000, C514S056000, C514S058000, C514S169000, C514S449000
Reexamination Certificate
active
08071571
ABSTRACT:
A pharmaceutical combination or composition containing a lipase inhibitor, preferably orlistat, and a bile acid sequestrant is useful for treating obesity.
REFERENCES:
patent: 3692895 (1972-09-01), Nelson et al.
patent: 4160826 (1979-07-01), Fishetti
patent: 4598089 (1986-07-01), Hadvary et al.
patent: 4902501 (1990-02-01), Bandi et al.
patent: 5063210 (1991-11-01), Lange et al.
patent: 5358522 (1994-10-01), Montgomery et al.
patent: 5447953 (1995-09-01), Isler et al.
patent: 5569452 (1996-10-01), Amidon et al.
patent: 5607669 (1997-03-01), Mandeville, III et al.
patent: 5612026 (1997-03-01), Diehl
patent: 5616570 (1997-04-01), Lange et al.
patent: 5643874 (1997-07-01), Bremer et al.
patent: 5667775 (1997-09-01), Holmes-Farley et al.
patent: 5679717 (1997-10-01), Mandeville, III et al.
patent: 5883109 (1999-03-01), Gregg et al.
patent: 6004996 (1999-12-01), Shah et al.
patent: 6030953 (2000-02-01), Bailly et al.
patent: 6358522 (2002-03-01), Hug et al.
patent: 6703369 (2004-03-01), Smidt et al.
patent: 2003/0181512 (2003-09-01), Smidt et al.
patent: 0815857 (2004-09-01), None
patent: 2780932 (1998-05-01), None
patent: 11-147828 (1999-02-01), None
patent: 2002-515365 (2002-05-01), None
patent: WO90/12579 (1990-11-01), None
patent: WO98/03069 (1998-01-01), None
patent: WO98/31367 (1998-07-01), None
patent: WO99/33450 (1999-07-01), None
patent: WO99/34786 (1999-07-01), None
patent: WO99/34787 (1999-07-01), None
patent: WO00/09122 (2000-02-01), None
patent: WO00/09123 (2000-02-01), None
patent: WO00/13667 (2000-03-01), None
patent: WO00/40569 (2000-07-01), None
patent: WO00/43036 (2000-07-01), None
patent: WO01/19340 (2001-03-01), None
patent: WO01/19378 (2001-03-01), None
Mutoch et al.,Journal of Antibiotics(1994):1369-1375.
Cavaliere et al.,Int. Journ. Obes. Relate. Metab. Disord. (2001) 25(7):1095-99.
Carbollo et al.,Revista Cubana de Invetigaciones Biomedicas(1997) 16(1):30-33.
Chertow et al.,Nephrology Dialysis Transplantation(1999) 14(12):2907-2914.
Hollander et al.,Diabetes Care(1998) 21(8):1288-1294.
Aronne, L.,Jour of the Amer. Diabetic Assoc. (1998) 98(10)(2):S23-6.
Wald, A.,Geriatrics(1997) 52(7):44-52.
Hvizdos et al.,.Drugs, (1999) 58(4):743-760.
Handbook of Pharmaceutical Excipients, 5thEdition, pp. 725-730.
Barbier Pierre
Hadvary Paul
Lengsfeld Hans
Hoffman-La Roche Inc.
Johnson George W.
Parise John P.
Peselev Elli
LandOfFree
Orlistat compositions does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Orlistat compositions, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Orlistat compositions will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4268797